Breaking News Instant updates and real-time market news.

FSB

Franklin Financial Network

$35.00

0.65 (1.89%)

06:19
11/22/16
11/22
06:19
11/22/16
06:19

Franklin Financial Network initiated with an Overweight at Piper Jaffray

Piper Jaffray analyst Peyton Green started Franklin Financial Network with an Overweight rating and $41.50 price target.

FSB Franklin Financial Network
$35.00

0.65 (1.89%)

06/29/16
BOFA
06/29/16
DOWNGRADE
Target $35
BOFA
Neutral
Franklin Financial Network downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill downgraded Franklin Financial to Neutral and lowering its price target to $35. The firm adjusted earnings estimates for the pushed out timeline of the Civic bank merger and a lower interest rate outlook, and expects shares to consolidate the significant gains since the company's 2015 IPO.
06/29/16
06/29/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on the today's top five analyst downgrades with this list compiled by The Fly: 1. HeartWare (HTWR) downgraded to Equal Weight from Overweight at Barclays by analyst Matthew Taylor, saying he does not expect a competing takeover bid to Medtronic's (MDT) offer. The analyst raised his price target for the shares to $58 from $35. Similarly, shares were downgraded to Market Perform from Outperform at Wells Fargo, with analyst Larry Biegelsen saying he sees a low likelihood that a higher bidder will emerge. The analyst believes Medtronic paid a fair valuation for HeartWare. HeartWare was also downgraded to Neutral from Buy at BTIG. 2. Esperion (ESPR) downgraded to Neutral from Overweight at JPMorgan by analyst Jessica Fye, who slashed her price target for shares to $15 from $50. The analyst says last night's regulatory update is a net negative. Disappointingly, the FDA did not sign off on the use of LDL-C lowering as an acceptable regulatory endpoint for approval of bempedoic acid for the treatment of statin-intolerant patients, Fye tells investors in a research note. The analyst still believes bempedoic acid is an effective LDL-C lowering agent, but now sees a drawn out path to approval in the U.S. Esperion was also downgraded to Underperform at Neutral at Credit Suisse by analyst Vamil Divan, who says the update on the development plans for bempedoic acid leaves him increasingly concerned about the products outlook in the U.S. market. The analyst was surprised that the FDA may not be willing to allow LDL-C as a surrogate endpoint for initial approval but believes there will be significant pressure, and limited upside, on shares until that certainty is obtained, and that process may take years to play out. Esperion was also downgraded to Sector Perform from Outperform at RBC Capital. 3. Comerica (CMA) downgraded to Underperform from Neutral at BofA/Merrill, which reduced its price target to $36 from $45. The firm's analyst lowered estimates 8% below consensus for 2016 and 17% below consensus in 2017 due to low rates that will pressure spread revenue growth, slower U.S. economic growth, and continued reserve build. The firm also downgraded Regions Financial (RF), Synovus (SNV), Texas Capital (TCBI) and Franklin Financial Network (FSB) to Neutral from Buy, as well as Zions Bancorp (ZION) to Underperform from Neutral. 4. comScore (SCOR) downgraded to Neutral from Positive at Susquehanna, citing uncertainty surrounding its accounting issues. The firm continues to like the long-term fundamental story, but with an unclear timeline for its resolution, they are moving to the sidelines. Susquehanna lowered its price target to $18 from $30 on comScore shares. 5. Harman (HAR) downgraded to Sector Perform from Outperform at RBC Capital partly based on the low number of new car launches next year, the firm's forecast for reduced production by the company's European customers, and the firm's reduction in its U.S. auto production versus its previous forecast. Additionally, the firm expects GM (GM) to delay a number of its connected car launches that had been slated for fiscal 2017 until fiscal 2018. The firm lowered its price target to $73 from $85. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/06/16
RAJA
09/06/16
INITIATION
Target $40
RAJA
Outperform
Franklin Financial Network initiated with an Outperform at Raymond James
Raymond James analyst Daniel Cardenas initiated Franklin Financial with an Outperform and $40 price target. The analyst said the company remains well positioned to continue to post double digit balance sheet and income statement growth, supported by a sound capital base and shareholder-oriented management team. He believes these factors leave the company well-positioned to experience a pickup in earnings power, tangible common equity levels, and tangible book value per share.

TODAY'S FREE FLY STORIES

NOW

ServiceNow

$90.00

-0.24 (-0.27%)

15:20
04/26/17
04/26
15:20
04/26/17
15:20
Options
ServiceNow options imply 10.6% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

MS

Morgan Stanley

$44.50

0.225 (0.51%)

15:18
04/26/17
04/26
15:18
04/26/17
15:18
Conference/Events
Morgan Stanley management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 09

    May

  • 22

    May

TRU

TransUnion

$39.72

0.92 (2.37%)

15:17
04/26/17
04/26
15:17
04/26/17
15:17
Conference/Events
TransUnion management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 03

    May

  • 09

    May

$NSD

NASDAQ Market Internals

15:17
04/26/17
04/26
15:17
04/26/17
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRB

H&R Block

$24.07

-0.175 (-0.72%)

, INTU

Intuit

$119.08

0.32 (0.27%)

15:17
04/26/17
04/26
15:17
04/26/17
15:17
Hot Stocks
Trump Effect: Tax preparers fall as administration promises simpler code »

Shares of publicly-traded…

HRB

H&R Block

$24.07

-0.175 (-0.72%)

INTU

Intuit

$119.08

0.32 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZION

Zions Bancorp

$40.49

-1.47 (-3.50%)

15:16
04/26/17
04/26
15:16
04/26/17
15:16
Conference/Events
Zions Bancorp management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

$NYE

NYSE Market Internals

15:16
04/26/17
04/26
15:16
04/26/17
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$40.34

0.4 (1.00%)

15:14
04/26/17
04/26
15:14
04/26/17
15:14
Hot Stocks
AT&T, IBEW reach tentative agreement in Midwest wireline contract negotiations »

AT&T announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 16

    May

  • 17

    May

ALNY

Alnylam

$51.35

1.05 (2.09%)

, IONS

Ionis Pharmaceuticals

$47.88

2.14 (4.68%)

15:12
04/26/17
04/26
15:12
04/26/17
15:12
Recommendations
Alnylam, Ionis Pharmaceuticals analyst commentary  »

Alnylam data for…

ALNY

Alnylam

$51.35

1.05 (2.09%)

IONS

Ionis Pharmaceuticals

$47.88

2.14 (4.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 09

    May

  • 12

    May

  • 24

    May

  • 06

    Jun

VIX

Volatility Index S&P 500 Options

$10.47

-0.29 (-2.70%)

15:11
04/26/17
04/26
15:11
04/26/17
15:11
Options
Quiet day in the VIX pit as markets see muted reaction to Trump's tax plan »

Quiet day in the VIX pit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$50.51

1.09 (2.21%)

15:10
04/26/17
04/26
15:10
04/26/17
15:10
Recommendations
Seagate analyst commentary  »

Needham would be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    Jun

FFIV

F5 Networks

$138.19

0.26 (0.19%)

15:05
04/26/17
04/26
15:05
04/26/17
15:05
Options
F5 Networks options imply 9.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

USB

U.S. Bancorp

$52.47

0.34 (0.65%)

15:01
04/26/17
04/26
15:01
04/26/17
15:01
Hot Stocks
U.S. Bank names Kate Quinn chief administrative officer »

U.S. Bank announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 19

    Jul

  • 18

    Oct

  • 17

    Jan

T

AT&T

$40.26

0.32 (0.80%)

15:00
04/26/17
04/26
15:00
04/26/17
15:00
Hot Stocks
AT&T CEO 'applauds' FCC initiative to remove 'regulatory cloud' over internet »

AT&T Chairman &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

  • 16

    May

  • 17

    May

AMZN

Amazon.com

$907.62

0.21 (0.02%)

14:55
04/26/17
04/26
14:55
04/26/17
14:55
Hot Stocks
Amazon debuts 'Echo Look' camera, style assistant »

Amazon debuted its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 16

    May

  • 16

    May

  • 23

    May

MENB

Mendocino Brewing Company, Inc.

14:52
04/26/17
04/26
14:52
04/26/17
14:52
Hot Stocks
Mendocino Brewing Company gets amendment to current credit facility »

Effective April 25,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNX

Mellanox

$50.95

-0.55 (-1.07%)

14:50
04/26/17
04/26
14:50
04/26/17
14:50
Options
Mellanox options imply 9.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 12

    Jun

TWTR

Twitter

$15.99

1.325 (9.04%)

14:47
04/26/17
04/26
14:47
04/26/17
14:47
Recommendations
Twitter analyst commentary  »

Twitter to be valued like…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ILG

ILG

$23.68

0.57 (2.47%)

14:41
04/26/17
04/26
14:41
04/26/17
14:41
Options
Notable interest in ILG in-the-money calls »

Notable interest in ILG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 25

    May

III

Information Services

$3.19

-0.02 (-0.62%)

14:38
04/26/17
04/26
14:38
04/26/17
14:38
Conference/Events
Information Services management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 09

    May

COF

Capital One

$83.86

-1.725 (-2.02%)

14:38
04/26/17
04/26
14:38
04/26/17
14:38
Downgrade
Capital One rating change  »

Capital One downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 31

    May

  • 06

    Jun

MCRN

Milacron

$19.17

0.37 (1.97%)

14:37
04/26/17
04/26
14:37
04/26/17
14:37
Hot Stocks
Milacron says DME subsidiary to expand Greenville facility »

Milacron Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 16

    May

  • 16

    May

SAGE

SAGE Therapeutics

$73.37

0.52 (0.71%)

14:36
04/26/17
04/26
14:36
04/26/17
14:36
Options
Sage Therapeutics put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

CB

Chubb

$139.25

2.13 (1.55%)

14:32
04/26/17
04/26
14:32
04/26/17
14:32
Recommendations
Chubb analyst commentary  »

Chubb price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 18

    May

STX

Seagate

$50.51

1.09 (2.21%)

14:26
04/26/17
04/26
14:26
04/26/17
14:26
Recommendations
Seagate analyst commentary  »

Seagate EPS growth should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.